Weighing telepsychiatry vs in-person care means holding two findings at once. Across many mental health conditions, video psychiatry performs about as well as sitting in the same room. For severe mental illness (SMI) such as schizophrenia and bipolar disorder, the trials simply have not been run, and parts of this care (injections, blood tests, physical checks, and crisis assessment) cannot travel through a screen at all. So the real question is rarely either-or. It is which parts of care can safely go virtual, which parts cannot, and who should be making that call as your stability changes over time. Here's what the research shows, and where the practical limits fall.
What Telepsychiatry Is and What In-Person Care Means
Telepsychiatry is psychiatric care delivered by video or phone: evaluations, medication visits, and therapy sessions held from wherever the patient is. In-person care means visits at a clinic, with the clinician and everything a clinic contains (labs, injections, vitals, a team down the hall) physically present. Between them sits hybrid care, a deliberate mix of both formats, which is how a great deal of psychiatric care in the United States now actually runs. The terms matter less than what each format can physically deliver, which is where the comparison gets concrete.
What the Research Shows
The broadest comparison to date is a 2023 meta-analysis in the British Journal of Psychiatry covering 32 randomized trials and 3,592 participants across 11 conditions (Hagi et al., 2023). Pooled together, there was no significant overall difference in symptom improvement between telepsychiatry and face-to-face treatment. By condition, telepsychiatry did better for depressive disorders, across 6 trials, and face-to-face did better for eating disorders, on the strength of a single trial. Dropout findings split the same way, each direction supported by one small study. Several of the condition-level results rest on a single trial, which makes them fragile rather than final, and the authors note as much.
That finding cuts in both directions. Video care is not a watered-down version of psychiatry; for depression in particular it holds up well, and dismissing it would misread the data. At the same time, a pooled average across 11 conditions says nothing about the conditions that never made it into the trials, and the trials skew toward the diagnoses that are easiest to study remotely.
What We Know, and Do Not Yet Know, About SMI
Schizophrenia and bipolar disorder are largely missing from this evidence. A 2022 systematic review in JMIR Mental Health went looking for randomized trials of telehealth psychotherapy and found 12 trials with 931 patients, none of which studied schizophrenia or bipolar disorder, leading the authors to call for high-quality research before treating telehealth as equivalent for these conditions (Greenwood et al., 2022). The Hagi meta-analysis likewise names neither condition among its findings. Narrative reviews describe telehealth with psychosis as feasible and acceptable, and feasibility is a different claim than tested equivalence.
The absence of strong trials is not proof that telepsychiatry harms people with severe mental illness, and it is not proof of equivalence either. For conditions this serious, that gap counsels care in what gets moved online, and it puts the burden on care models to show their format choices serve the patient rather than the schedule.
What Needs to Happen In Person
Some components of SMI treatment are physical, and no quality of webcam changes that:
- Long-acting injectable antipsychotics are administered by a clinician, on a schedule, in person. For many people they are the backbone of stability.
- Blood monitoring comes with several core SMI medications: lithium levels, the regular blood counts recommended with clozapine, and metabolic monitoring for people on antipsychotics, per each medication's prescribing requirements. These need a clinic or a lab, not a login.
- Physical exams and vitals catch the medical problems that psychiatric medications can cause and that psychiatric illness so often hides from everyone, including the patient.
- Interventional treatments such as TMS and Spravato are delivered in clinic under supervision, by design.
- Crisis assessment is a hands-on clinical skill. Judging safety through a screen, with a person who may not want to be seen clearly and can end the call at will, is a genuinely harder task than assessing someone in the room.
For severe mental illness, these are routine, recurring parts of treatment rather than rare events, which is why fully remote care for this population runs into walls that have nothing to do with anyone's opinion of telehealth. A care plan that includes an injectable every four weeks and quarterly labs has an in-person spine no matter how the conversations happen.
Where Telepsychiatry Fits Well
Video visits earn their place in several situations: stable follow-ups and medication check-ins once a plan is working, access for people who live far from psychiatric care or cannot travel easily, and flexibility for family members joining a session from different places. For a routine fifteen-minute medication review in a stable month, driving an hour each way serves nobody.
Those are real advantages, and they come with real conditions. A video visit requires privacy at home, which not every household offers, a reliable connection, and the ability to engage through a screen, each of which gets harder exactly when symptoms are most active. Paranoia can make a camera feel threatening; depression can make logging in feel impossible. The format works best for the stable stretches of an illness that does not always stay stable.
Hybrid Care and Level of Need
The workable frame is level of need rather than loyalty to a format. Someone newly stabilized after a hospitalization needs more in-person contact: labs, physical checks, possibly injections, a team reading them closely. Someone two stable years into treatment may handle routine visits by video and come in for bloodwork and periodic full evaluations. A rough month might mean temporarily moving visits back on site.
The mix should shift as stability shifts, in both directions, and the people best positioned to adjust it are a care team who knows the whole picture, the same logic that separates outpatient from inpatient levels of care.
Why a Coordinated, In-Person Team Matters for SMI
Severe mental illness is a whole-body, whole-life illness, and people living with it face higher rates of serious physical illness, so treating it takes more than a sequence of appointments in any format. At Amae Health, one team (psychiatrists, therapists, and primary care physicians, along with peer mentors, care coordinators, dietitians, and health coaches) works from a shared plan in one place, so the injection, the lab draw, the therapy session, and the medical follow-up belong to one plan rather than four calendars. That is the part of care a screen cannot substitute for: not the conversation, which video carries fine, but the coordination and the physical medicine around it. It is the model behind our psychosis care and bipolar disorder treatment, and our full care model shows how the pieces fit.
Talking to Our Care Team About the Right Format
The right format is a clinical question with a moving answer: it depends on your current symptoms, your medications and their monitoring, your stability, and your goals. A first conversation can settle where to start and how to adjust from there. Reach out to our care team about the right format for this stage, and our patient and family resources describe what coordinated care involves.
Frequently Asked Questions
Is telepsychiatry as effective as in-person psychiatry?
For many conditions, yes. A 2023 meta-analysis of 32 randomized trials found no significant overall difference in symptom improvement, and telepsychiatry did best for depressive disorders. Results vary by condition, and evidence for schizophrenia and bipolar disorder specifically is limited.
Is telepsychiatry effective for schizophrenia?
The research is thin. A 2022 systematic review found no eligible randomized trials of telehealth psychotherapy for schizophrenia, while narrative reviews describe telehealth with psychosis as feasible and acceptable. Limited research is the accurate summary, not evidence of failure.
Can long-acting injectable antipsychotics be given by telehealth?
No. Injections are administered in person by a clinician, so people on long-acting injectables need in-person visits on their injection schedule, whatever else happens by video.
Do I need blood tests or physical checks with serious mental illness?
Often, yes, depending on the medication. Lithium requires blood level checks, clozapine calls for regular blood monitoring, and antipsychotics call for metabolic monitoring under their prescribing requirements, all of which involve a clinic or lab visit.
Can telepsychiatry handle a mental health crisis?
No. Video visits are not built for emergencies. In a crisis, call or text 988 or go to the nearest emergency room; a care team can take over treatment planning once the person is safe.
What is hybrid psychiatric care?
A deliberate mix of in-person and video visits, adjusted over time as stability and needs change. In-person time covers the parts of care that require presence, such as injections and labs, while routine check-ins can happen by video.
What if I am having thoughts of suicide?
Help is available right now, at any hour: call or text 988 for free, confidential support.
Citations
- Hagi K, et al. "Telepsychiatry versus face-to-face treatment: systematic review and meta-analysis of randomised controlled trials." British Journal of Psychiatry, 2023;223(3):407-414. doi.org/10.1192/bjp.2023.86. Tier 1 (peer-reviewed meta-analysis).
- Greenwood H, et al. "Telehealth versus face-to-face psychotherapy for less common mental health conditions: systematic review and meta-analysis." JMIR Mental Health, 2022;9(3):e31780. PMC8956990. Tier 1 (peer-reviewed systematic review).
- 988 Suicide and Crisis Lifeline. 988lifeline.org. Tier 2 (FAQ only).
